Orhpan Drug Credit

ICR 200601-1545-005

OMB: 1545-1505

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
IC Document Collections
IC ID
Document
Title
Status
18532 Migrated
ICR Details
1545-1505 200601-1545-005
Historical Active 200409-1545-054
TREAS/IRS
Orhpan Drug Credit
Extension without change of a currently approved collection   No
Regular
Approved without change 03/02/2006
Retrieve Notice of Action (NOA) 01/06/2006
  Inventory as of this Action Requested Previously Approved
03/31/2009 03/31/2009 03/31/2006
67 0 100
511 0 762
0 0 0

Filers use this form to elect to claim the orphan drug credit, which is 50% of the qualified clinical testing expenses paid or incurred with respect to low or unprofitable drugs for rare diseases and conditions, as designated under section 526 of the Federal Food, Drug, and Cosmetic Act.

None
None


No

1
IC Title Form No. Form Name
Orhpan Drug Credit 8820

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 67 100 0 0 -33 0
Annual Time Burden (Hours) 511 762 0 0 -251 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/06/2006


© 2024 OMB.report | Privacy Policy